CID 3055168

Rivoglitazone

Structural Information

Molecular Formula
C20H19N3O4S
SMILES
CN1C2=C(C=CC(=C2)OC)N=C1COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4
InChI
InChI=1S/C20H19N3O4S/c1-23-16-10-14(26-2)7-8-15(16)21-18(23)11-27-13-5-3-12(4-6-13)9-17-19(24)22-20(25)28-17/h3-8,10,17H,9,11H2,1-2H3,(H,22,24,25)
InChIKey
XMSXOLDPMGMWTH-UHFFFAOYSA-N
Compound name
5-[[4-[(6-methoxy-1-methylbenzimidazol-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

15
References

6917
Patents

397.10962 Da
Monoisotopic Mass

3.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 398.11690 193.2
[M+Na]+ 420.09884 203.9
[M-H]- 396.10234 200.5
[M+NH4]+ 415.14344 205.3
[M+K]+ 436.07278 197.9
[M+H-H2O]+ 380.10688 185.3
[M+HCOO]- 442.10782 207.9
[M+CH3COO]- 456.12347 203.4
[M+Na-2H]- 418.08429 189.9
[M]+ 397.10907 199.8
[M]- 397.11017 199.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe